| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Occupational Injuries | 1 | 2021 | 148 | 0.74 | Why? |
| Ventricular Remodeling | 3 | 2018 | 349 | 0.71 | Why? |
| Transitional Care | 1 | 2018 | 135 | 0.62 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.47 | Why? |
| Doxorubicin | 3 | 2019 | 313 | 0.45 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.44 | Why? |
| Autism Spectrum Disorder | 1 | 2018 | 587 | 0.40 | Why? |
| Home Care Services | 2 | 2018 | 1351 | 0.38 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.38 | Why? |
| Connexin 43 | 2 | 2018 | 37 | 0.36 | Why? |
| Parathyroid Hormone | 2 | 2018 | 98 | 0.36 | Why? |
| Heart | 1 | 2018 | 1791 | 0.35 | Why? |
| Mitochondria | 4 | 2019 | 857 | 0.35 | Why? |
| Myocytes, Cardiac | 3 | 2019 | 804 | 0.33 | Why? |
| G-Protein-Coupled Receptor Kinase 2 | 2 | 2019 | 9 | 0.32 | Why? |
| Shoulder Fractures | 2 | 2017 | 18 | 0.30 | Why? |
| Oxidative Stress | 5 | 2019 | 2050 | 0.30 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.27 | Why? |
| Parents | 1 | 2018 | 2758 | 0.26 | Why? |
| Dementia | 1 | 2017 | 1861 | 0.26 | Why? |
| Fracture Fixation, Internal | 2 | 2017 | 188 | 0.26 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.24 | Why? |
| Energy Metabolism | 2 | 2017 | 451 | 0.24 | Why? |
| Hyperparathyroidism | 1 | 2021 | 38 | 0.22 | Why? |
| Chromosomes, Human, Pair 9 | 2 | 2020 | 196 | 0.22 | Why? |
| Workers' Compensation | 1 | 2021 | 40 | 0.22 | Why? |
| Cardiotoxicity | 3 | 2019 | 365 | 0.21 | Why? |
| Antibiotics, Antineoplastic | 2 | 2019 | 128 | 0.21 | Why? |
| G-Protein-Coupled Receptor Kinase 5 | 1 | 2018 | 3 | 0.20 | Why? |
| Antihypertensive Agents | 3 | 2020 | 1962 | 0.20 | Why? |
| Sarcomeres | 1 | 2018 | 7 | 0.19 | Why? |
| Diazoxide | 1 | 2018 | 3 | 0.19 | Why? |
| Serum Amyloid P-Component | 1 | 2020 | 193 | 0.19 | Why? |
| Neurotransmitter Agents | 1 | 2019 | 57 | 0.19 | Why? |
| Child Development Disorders, Pervasive | 1 | 2018 | 17 | 0.19 | Why? |
| Anti-Citrullinated Protein Antibodies | 1 | 2018 | 40 | 0.18 | Why? |
| Chromosomes, Human, Pair 3 | 1 | 2020 | 195 | 0.18 | Why? |
| Protective Agents | 2 | 2019 | 250 | 0.18 | Why? |
| gamma-Globulins | 1 | 2018 | 73 | 0.18 | Why? |
| Phenylalanine | 1 | 2019 | 122 | 0.18 | Why? |
| Calcium | 3 | 2018 | 708 | 0.18 | Why? |
| Ilium | 1 | 2017 | 22 | 0.18 | Why? |
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2017 | 10 | 0.18 | Why? |
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 13 | 0.18 | Why? |
| Bone Transplantation | 1 | 2017 | 38 | 0.18 | Why? |
| Hospital Mortality | 6 | 2021 | 22087 | 0.18 | Why? |
| Ventricular Function | 1 | 2018 | 93 | 0.18 | Why? |
| Fracture Healing | 1 | 2017 | 37 | 0.18 | Why? |
| Glenoid Cavity | 1 | 2016 | 1 | 0.17 | Why? |
| Pneumonia, Pneumococcal | 1 | 2020 | 251 | 0.17 | Why? |
| Mitochondria, Heart | 1 | 2017 | 37 | 0.17 | Why? |
| B7-H1 Antigen | 1 | 2021 | 541 | 0.17 | Why? |
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 27 | 0.17 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.17 | Why? |
| Shoulder Dislocation | 1 | 2016 | 18 | 0.17 | Why? |
| Bronchoalveolar Lavage | 1 | 2021 | 603 | 0.17 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2019 | 192 | 0.16 | Why? |
| Arthroscopy | 1 | 2016 | 46 | 0.16 | Why? |
| Arthroplasty | 1 | 2016 | 59 | 0.16 | Why? |
| Fluorodeoxyglucose F18 | 2 | 2021 | 1153 | 0.16 | Why? |
| Protein Kinases | 1 | 2017 | 93 | 0.16 | Why? |
| Cardiotonic Agents | 1 | 2019 | 418 | 0.15 | Why? |
| Vitamin D Deficiency | 2 | 2021 | 1782 | 0.15 | Why? |
| Telemetry | 1 | 2018 | 240 | 0.15 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2020 | 3607 | 0.15 | Why? |
| Reactive Oxygen Species | 2 | 2018 | 1136 | 0.15 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.15 | Why? |
| Carotid Arteries | 1 | 2016 | 182 | 0.14 | Why? |
| Return to Work | 1 | 2021 | 579 | 0.14 | Why? |
| Heparin, Low-Molecular-Weight | 2 | 2020 | 1731 | 0.14 | Why? |
| Occupational Therapy | 1 | 2017 | 228 | 0.13 | Why? |
| Vasculitis | 1 | 2020 | 691 | 0.13 | Why? |
| Carotid Artery Diseases | 1 | 2016 | 251 | 0.13 | Why? |
| Mentors | 1 | 2017 | 372 | 0.13 | Why? |
| Thyroid Neoplasms | 1 | 2018 | 422 | 0.13 | Why? |
| Autistic Disorder | 1 | 2017 | 253 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 1 | 2020 | 1215 | 0.12 | Why? |
| Receptors, Interleukin-6 | 1 | 2020 | 1383 | 0.12 | Why? |
| Plaque, Atherosclerotic | 1 | 2016 | 423 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Aged | 22 | 2021 | 215776 | 0.11 | Why? |
| Ferritins | 1 | 2020 | 2055 | 0.11 | Why? |
| Pleural Effusion | 1 | 2017 | 680 | 0.11 | Why? |
| NF-kappa B | 1 | 2018 | 1301 | 0.11 | Why? |
| ABO Blood-Group System | 1 | 2020 | 995 | 0.11 | Why? |
| Macrophages | 2 | 2020 | 2784 | 0.11 | Why? |
| Mentoring | 1 | 2017 | 432 | 0.11 | Why? |
| Intellectual Disability | 1 | 2017 | 391 | 0.11 | Why? |
| Independent Living | 1 | 2017 | 842 | 0.11 | Why? |
| Signal Transduction | 5 | 2019 | 7207 | 0.11 | Why? |
| Genetic Predisposition to Disease | 3 | 2020 | 4027 | 0.10 | Why? |
| Heart Injuries | 1 | 2017 | 608 | 0.10 | Why? |
| Cardiovascular Diseases | 3 | 2021 | 11497 | 0.10 | Why? |
| Male | 31 | 2021 | 367725 | 0.10 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.10 | Why? |
| Hypertension | 3 | 2021 | 8895 | 0.10 | Why? |
| Radiography | 1 | 2017 | 1576 | 0.10 | Why? |
| Immune System | 1 | 2019 | 1479 | 0.10 | Why? |
| Respiratory Insufficiency | 2 | 2021 | 7301 | 0.09 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.09 | Why? |
| Gene Expression Profiling | 1 | 2020 | 3788 | 0.09 | Why? |
| Protein Kinase Inhibitors | 1 | 2019 | 1585 | 0.09 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 1510 | 0.09 | Why? |
| Italy | 10 | 2021 | 38444 | 0.09 | Why? |
| Female | 28 | 2021 | 380317 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.09 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.09 | Why? |
| Amides | 1 | 2019 | 1864 | 0.08 | Why? |
| Australia | 1 | 2021 | 6306 | 0.08 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.08 | Why? |
| Middle Aged | 23 | 2021 | 270681 | 0.08 | Why? |
| Humans | 40 | 2021 | 930598 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.08 | Why? |
| Range of Motion, Articular | 2 | 2017 | 168 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2018 | 1549 | 0.08 | Why? |
| Hypoglycemic Agents | 1 | 2019 | 2165 | 0.08 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.07 | Why? |
| Radiopharmaceuticals | 2 | 2021 | 763 | 0.07 | Why? |
| Residence Characteristics | 1 | 2016 | 1927 | 0.07 | Why? |
| Qualitative Research | 1 | 2017 | 4337 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| Treatment Outcome | 9 | 2021 | 51732 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.07 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.07 | Why? |
| Adolescent | 7 | 2018 | 86841 | 0.07 | Why? |
| Multivariate Analysis | 3 | 2020 | 5440 | 0.06 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.06 | Why? |
| Arrhythmias, Cardiac | 1 | 2017 | 2510 | 0.06 | Why? |
| Aged, 80 and over | 10 | 2021 | 88759 | 0.06 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.06 | Why? |
| Protective Factors | 2 | 2020 | 1720 | 0.06 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.06 | Why? |
| Phenotype | 3 | 2018 | 4037 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.06 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.06 | Why? |
| Public Health Surveillance | 1 | 2016 | 3129 | 0.06 | Why? |
| Adult | 14 | 2021 | 244371 | 0.06 | Why? |
| Mice | 5 | 2019 | 21357 | 0.06 | Why? |
| Animals | 10 | 2019 | 78931 | 0.06 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.06 | Why? |
| Schools | 1 | 2017 | 4187 | 0.06 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.05 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 1458 | 0.05 | Why? |
| Case-Control Studies | 4 | 2021 | 17671 | 0.05 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Levofloxacin | 1 | 2020 | 115 | 0.05 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.05 | Why? |
| Myoblasts | 1 | 2019 | 24 | 0.05 | Why? |
| Butyric Acid | 1 | 2019 | 27 | 0.05 | Why? |
| Cobicistat | 1 | 2020 | 172 | 0.05 | Why? |
| Publication Bias | 1 | 2021 | 241 | 0.05 | Why? |
| Butyrates | 1 | 2019 | 31 | 0.05 | Why? |
| Receptor, Bradykinin B2 | 1 | 2018 | 31 | 0.05 | Why? |
| Organophosphorus Compounds | 1 | 2018 | 53 | 0.05 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.05 | Why? |
| Acetylcholine | 1 | 2018 | 53 | 0.05 | Why? |
| Endothelial Cells | 2 | 2020 | 2048 | 0.05 | Why? |
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2018 | 66 | 0.05 | Why? |
| Tumor Cells, Cultured | 1 | 2018 | 254 | 0.05 | Why? |
| Genetic Loci | 1 | 2020 | 439 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| Calcium Channels | 1 | 2018 | 96 | 0.05 | Why? |
| Cardiomegaly | 1 | 2019 | 96 | 0.05 | Why? |
| Program Evaluation | 2 | 2017 | 1929 | 0.05 | Why? |
| Ceftriaxone | 1 | 2020 | 365 | 0.05 | Why? |
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2017 | 16 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Apoptosis | 2 | 2019 | 2335 | 0.04 | Why? |
| Bone Plates | 1 | 2017 | 26 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.04 | Why? |
| Sex Factors | 3 | 2021 | 11014 | 0.04 | Why? |
| Biological Transport | 1 | 2019 | 290 | 0.04 | Why? |
| Echocardiography | 3 | 2019 | 3661 | 0.04 | Why? |
| Mice, Nude | 1 | 2018 | 340 | 0.04 | Why? |
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 45 | 0.04 | Why? |
| Mutation | 1 | 2018 | 12376 | 0.04 | Why? |
| Neovascularization, Physiologic | 1 | 2018 | 160 | 0.04 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.04 | Why? |
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.04 | Why? |
| Scapula | 1 | 2016 | 7 | 0.04 | Why? |
| Heart Function Tests | 1 | 2018 | 101 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Antigens, Bacterial | 1 | 2020 | 330 | 0.04 | Why? |
| Rotator Cuff | 1 | 2016 | 15 | 0.04 | Why? |
| Joint Instability | 1 | 2016 | 20 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| Analysis of Variance | 1 | 2021 | 950 | 0.04 | Why? |
| Cells, Cultured | 2 | 2020 | 5835 | 0.04 | Why? |
| Mitochondrial Dynamics | 1 | 2017 | 30 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2019 | 5542 | 0.04 | Why? |
| Calcium-Binding Proteins | 1 | 2017 | 121 | 0.04 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.04 | Why? |
| Membrane Potential, Mitochondrial | 1 | 2017 | 102 | 0.04 | Why? |
| Culture Media, Conditioned | 1 | 2016 | 66 | 0.04 | Why? |
| Rupture, Spontaneous | 1 | 2016 | 115 | 0.04 | Why? |
| Myocardium | 2 | 2019 | 2323 | 0.04 | Why? |
| Bradykinin | 1 | 2018 | 203 | 0.04 | Why? |
| Echocardiography, Doppler | 1 | 2018 | 269 | 0.04 | Why? |
| Protein Transport | 1 | 2018 | 487 | 0.04 | Why? |
| Endarterectomy, Carotid | 1 | 2016 | 78 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2016 | 86 | 0.04 | Why? |
| Monocytes | 2 | 2020 | 2978 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Infusions, Intravenous | 1 | 2020 | 1224 | 0.04 | Why? |
| Disease Models, Animal | 3 | 2019 | 10998 | 0.04 | Why? |
| Pilot Projects | 2 | 2018 | 5182 | 0.04 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.04 | Why? |
| Myocytes, Smooth Muscle | 1 | 2016 | 127 | 0.04 | Why? |
| Enzyme Activation | 1 | 2016 | 425 | 0.04 | Why? |
| Streptococcus pneumoniae | 1 | 2020 | 827 | 0.04 | Why? |
| Positron-Emission Tomography | 1 | 2020 | 802 | 0.04 | Why? |
| Action Potentials | 1 | 2017 | 368 | 0.04 | Why? |
| Predictive Value of Tests | 2 | 2020 | 9537 | 0.04 | Why? |
| Myocardial Infarction | 1 | 2011 | 3361 | 0.03 | Why? |
| Glucose | 1 | 2019 | 573 | 0.03 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.03 | Why? |
| A549 Cells | 1 | 2020 | 2066 | 0.03 | Why? |
| Cell Death | 1 | 2017 | 536 | 0.03 | Why? |
| Macrophage Activation | 1 | 2016 | 315 | 0.03 | Why? |
| Adenosine Triphosphate | 1 | 2017 | 294 | 0.03 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.03 | Why? |
| Cattle | 1 | 2018 | 1336 | 0.03 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Anti-Arrhythmia Agents | 1 | 2017 | 325 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2020 | 2324 | 0.03 | Why? |
| Insulin Resistance | 1 | 2019 | 669 | 0.03 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Prednisone | 1 | 2017 | 652 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.03 | Why? |
| Follow-Up Studies | 3 | 2017 | 17020 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Neoplasms | 1 | 2021 | 17251 | 0.03 | Why? |
| Patient Care Planning | 1 | 2017 | 582 | 0.03 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2020 | 3608 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Child | 2 | 2018 | 70012 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.03 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.03 | Why? |
| Immunomodulation | 1 | 2019 | 1472 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Mental Health | 1 | 2016 | 15770 | 0.02 | Why? |
| Epithelial Cells | 1 | 2021 | 3508 | 0.02 | Why? |
| Psychometrics | 1 | 2016 | 1269 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Smoking | 1 | 2021 | 3358 | 0.02 | Why? |
| Recovery of Function | 1 | 2017 | 2461 | 0.02 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.02 | Why? |
| Protein Domains | 1 | 2018 | 6563 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.02 | Why? |
| Neutrophils | 1 | 2020 | 5476 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Models, Biological | 1 | 2019 | 4907 | 0.01 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.01 | Why? |
| Stroke Volume | 1 | 2011 | 2153 | 0.01 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Registries | 1 | 2020 | 12327 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2016 | 8495 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Electrocardiography | 1 | 2011 | 3957 | 0.01 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Cytokines | 1 | 2016 | 15010 | 0.01 | Why? |
| China | 1 | 2021 | 50654 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Child, Preschool | 1 | 2016 | 36283 | 0.01 | Why? |